51
Views
20
CrossRef citations to date
0
Altmetric
Original Research

Clinical significance of CMTM4 expression in hepatocellular carcinoma

, , , , , , & show all
Pages 5439-5443 | Published online: 14 Nov 2017

References

  • KamangarFDoresGMAndersonWFPatterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the worldJ Clin Oncol200624142137215016682732
  • SiegelRLMillerKDJemalACancer Statistics, 2017CA Cancer J Clin201767173028055103
  • ZhuQLiNZengXHepatocellular carcinoma in a large medical center of China over a 10-year period: evolving therapeutic option and improving survivalOncotarget2015664440445025686836
  • LiuLMiaoRYangHPrognostic factors after liver resection for hepatocellular carcinoma: a single-center experience from ChinaAm J Surg2012203674175022177551
  • LeeSCTanHTChungMCPrognostic biomarkers for prediction of recurrence of hepatocellular carcinoma: current status and future prospectsWorld J Gastroenterol201420123112312424696598
  • GaoQWangXYZhouJFanJMultiple carcinogenesis contributes to the heterogeneity of HCCNat Rev Gastroenterol Hepatol20151211325421581
  • LuoWZhuXLiuWMYC associated zinc finger protein promotes the invasion and metastasis of hepatocellular carcinoma by inducing epithelial mesenchymal transitionOncotarget2016752864208643227861158
  • ZhuXWangZQiuXAssociations between single nucleotide polymorphisms in RYBP and the prognosis of hepatocellular carcinoma in a Chinese populationCarcinogenesis201738553254028369212
  • ChuaHHTsueiDJLeePHRBMY, a novel inhibitor of glycogen synthase kinase 3beta, increases tumor stemness and predicts poor prognosis of hepatocellular carcinomaHepatology20156251480149626185016
  • ChenHAKuoTCTsengCFAngiopoietin-like protein 1 antagonizes MET receptor activity to repress sorafenib resistance and cancer stemness in hepatocellular carcinomaHepatology20166451637165127530187
  • DowningTEOktayMHFazzariMJMontagnaCPrognostic and predictive value of 16p12.1 and 16q22.1 copy number changes in human breast cancerCancer Genet Cytogenet20101981526120303015
  • KeckBEllmannCStoehrRComparative genomic hybridization shows complex genomic changes of plasmacytoid urothelial carcinomaUrol Oncol20143281234123925087089
  • FuLDongSSXieYWDown-regulation of tyrosine aminotransferase at a frequently deleted region 16q22 contributes to the pathogenesis of hepatocellular carcinomaHepatology20105151624163420209601
  • CzarneckaKHMigdalska-SekMAntczakAAllelic imbalance in 1p, 7q, 9p, 11p, 12q and 16q regions in non-small cell lung carcinoma and its clinical association: a pilot studyMol Biol Rep201340126671668424091944
  • ZhangHZhangXYuanXWangLXiaoYMicroRNA-205 inhibits renal cells apoptosis via targeting CMTM4Iran J Basic Med Sci201518101020102626730338
  • PlateMLiTWangYIdentification and characterization of CMTM4, a novel gene with inhibitory effects on HeLa cell growth through Inducing G2/M phase accumulationMol Cells201029435536120213316
  • LiTChengYWangPCMTM4 is frequently downregulated and functions as a tumour suppressor in clear cell renal cell carcinomaJ Exp Clin Cancer Res20153412226474560
  • RaynalNJLeeJTWangYTargeting Calcium signaling induces epigenetic reactivation of tumor suppressor genes in cancerCancer Res20167661494150526719529
  • KellyTKDe CarvalhoDDJonesPAEpigenetic modifications as therapeutic targetsNat Biotechnol201028101069107820944599
  • TabyRIssaJPCancer epigeneticsCA Cancer J Clin201060637639220959400
  • VillanuevaAHoshidaYBattistonCCombining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinomaGastroenterology2011140515011512.e221320499
  • BruixJBoixLSalaMLlovetJMFocus on hepatocellular carcinomaCancer Cell20045321521915050913
  • LamVWNgKKChokKSRisk factors and prognostic factors of local recurrence after radiofrequency ablation of hepatocellular carcinomaJ Am Coll Surg20082071202918589357
  • JinJNiuXZouLAFP mRNA level in enriched circulating tumor cells from hepatocellular carcinoma patient blood samples is a pivotal predictive marker for metastasisCancer Lett20163781333727160647
  • XiaoSChangRMYangMYActin-like 6A predicts poor prognosis of hepatocellular carcinoma and promotes metastasis and epithelial-mesenchymal transitionHepatology20166341256127126698646
  • ZhuAXChenDHeWIntegrative biomarker analyses indicate etiological variations in hepatocellular carcinomaJ Hepatol201665229630427130844
  • UchinoKTateishiRShiinaSHepatocellular carcinoma with extrahepatic metastasis: clinical features and prognostic factorsCancer2011117194475448321437884
  • FarinatiFVitaleASpolveratoGDevelopment and validation of a new prognostic system for patients with hepatocellular carcinomaPLoS Med2016134e100200627116206